MetaADEDB 2.0 @ LMMD
Formaldehyde
(WSFSSNUMVMOOMR-UHFFFAOYSA-N)
Structure
SMILES
C=O
Type(s)
Approved; Vet_approved
Molecular Formula:
CH2O
Molecular Weight:
30.026
Log P:
0.4510
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
0
TPSA:
17.07
CAS Number(s):
50-00-0; 30525-89-4
Synonym(s)
1.
Formaldehyde
2.
Formalin
3.
Formol
4.
Methanal
5.
Oxomethane
External Link(s)
MeSHD005557
PubChem Compound712
ChEBI16842
CHEMBLCHEMBL1255
DrugBankDB03843
DrugCentral3244
IUPHAR/BPS Guide to PHARMACOLOGY4196
KEGGcpd:C00067
dr:D00017
dr:D01494
Therapeutic Target DatabaseD01KEE
D00STN
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute Lung Injury25845602CTD
2Adenocarcinoma12562630CTD
3Adenomatous Polyps12562630CTD
4Adenoma12562630CTD
5Asthenozoospermia16909603CTD
6Asthma

View details

CTD
7Atrioventricular Block4028383CTD
8Birth Weight24844129CTD
9Body Weight Changes27339418CTD
10BradycardiaCanada Vigilance: 1Canada Vigilance
11Bronchial Hyperreactivity14656365
16463957
CTD
12Chemical and Drug Induced Liver Injury17283889
20207655
CTD
13Chromosome Aberrations

View details

CTD
14Ciliophora Infections12113305CTD
15Cognition Disorders30395894CTD
16Completed SuicideCanada Vigilance: 2Canada Vigilance
17Conjunctivitis1683282CTD
18Cystitis566262
6134004
CTD
19Depressive disorder14633228CTD
20Dermatitis, Allergic Contact

View details

CTD
21Dermatitis, Atopic15218738CTD
22Dermatitis, Irritant17408435CTD
23Dermatitis, Occupational18976378CTD
24DermatitisCanada Vigilance: 1Canada Vigilance
25Diarrhea1683282CTD
26Disease Progression24060340CTD
27Disorders of Environmental Origin17938725CTD
28Dizziness1683282CTD
29Dry Eye Syndromes29860525CTD
30Dyspnea1683282CTD
31Eczema18063241CTD
32Edema

View details

CTD
33Epistaxis1683282
28081750
CTD
34Exanthema1683282CTD
35Extravasation of Diagnostic and Therapeutic Materials19014991CTD
36Eyelid Diseases14996049CTD
37Facial Pain

View details

CTD
38Fatigue1683282
17408435
21294402
CTD
39Fish Diseases12113305CTD
40Headache1683282
12833854
CTD
41Hematuria

View details

CTD
42Hemorrhage

View details

CTD
43Hyperalgesia

View details

CTD
44Hyperplasia16036858
20884683
CTD
45Hypersensitivity20123097
24844129
CTD
46Immunologic Deficiency Syndromes27020608CTD
47Inflammation

View details

CTD
48Intestinal Neoplasms12562630CTD
49Kidney Diseases14633228
16898265
18717515
CTD
50Lung Neoplasms14600093CTD
51Lung diseases20658762CTD
52Metabolic acidosisCanada Vigilance: 1Canada Vigilance
53Metaplasia

View details

CTD
54Nasopharyngeal Neoplasms12857938
15191929
CTD
55Nausea1683282CTD
56Necrosis14963899
20884683
CTD
57Neoplasm Invasiveness30236600CTD
58Nerve Degeneration15820619
30395894
CTD
59Neuralgia18492948
18544896
CTD
60Neuropathy, Painful23747933CTD
61Neurotoxicity Syndromes15648056
16397905
CTD
62Nociceptive Pain

View details

CTD
63Nose Neoplasms4038687CTD
64Occupational Diseases11519088
17002712
CTD
65Oligospermia16909603
24142868
CTD
66Pain

View details

CTD
67Periodontitis12751685CTD
68Pharyngitis1683282CTD
69Pneumonia21983654CTD
70Poisoning22157354
23649840
CTD
71Prenatal Exposure Delayed Effects24844129
25845602
27020608
CTD
72Proctitis12780922CTD
73Pulmonary Fibrosis29758289CTD
74Pulpitis12751685CTD
75Respiratory FailureCanada Vigilance: 1Canada Vigilance
76Respiratory Hypersensitivity15003329
29758289
CTD
77Respiratory Tract Infections21810553CTD
78Sneezing27545873CTD
79Stomach Neoplasms12562630CTD
80Testicular Neoplasms12562630CTD
81Ulcer14633228
20884683
CTD
82Urinary Bladder Diseases4203163CTD
83Urticaria12371530
15628056
17680969
CTD
84Vasculitis, Leukocytoclastic, Cutaneous17680969CTD
85Ventricular FibrillationCanada Vigilance: 1Canada Vigilance
86Warts16415283CTD
87fibroma12562630CTD
88leiomyosarcoma12562630CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.